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Introduction {#sec001}
============

Patients with severe mental illness (SMI) have a higher burden of premature cardio-metabolic abnormalities, including diabetes mellitus, hypertension, hyperlipidemia, and obesity compared to the general population. As a result, these patients tend to have up to a 3-fold increase in mortality and a reduction in life expectancy \[[@pone.0235956.ref001], [@pone.0235956.ref002]\]. In fact, patients with SMI die on average 20--30 years earlier than their counterparts without SMI \[[@pone.0235956.ref003]\] and it has been established that 50--75% of patients with SMI die as a result of cardiovascular disease \[[@pone.0235956.ref004]\].

Two meta-analyses of systematic metabolic monitoring of patients with schizophrenia and bipolar disorder found that about one in two (50%) had obesity, one in three (33%) had diabetes mellitus or prediabetes, two in five (40%) had hypertriglyceridemia, and two in five (40%) had hypertension \[[@pone.0235956.ref005], [@pone.0235956.ref006]\]. This high prevalence of cardio-metabolic abnormalities is linked to deleterious lifestyles common among patients with SMI such as unhealthy dietary choices, excessive alcohol consumption, smoking and reduced physical activity \[[@pone.0235956.ref007]\] in addition to obesogenic side effects of antipsychotic medication \[[@pone.0235956.ref008]\].

There is a lot of variation in the rates of cardio-metabolic screening in people with SMI \[[@pone.0235956.ref009], [@pone.0235956.ref010]\], with high screening rates observed in high-income countries such as United States of America \[[@pone.0235956.ref011]\] but very low rates of screening of about only 0.6% in low-income countries \[[@pone.0235956.ref012]\]. The low screening rates result in late diagnosis of these abnormalities at stages where lifestyle modification approaches are no longer very beneficial, thus leading to progression to cardiovascular disease.

Although over 30% of Ugandans have some form of mental illness \[[@pone.0235956.ref013]\], there are no national or hospital-based screening guidelines for cardio-metabolic abnormalities among patients with SMI. Thus far, data on cardio-metabolic abnormalities among patients with SMI in Uganda are limited. The aim of this study was to describe the cardio-metabolic abnormalities among patients with SMI attending the outpatient mental health clinic at Mbarara Regional Referral Hospital (MRRH). Documenting the burden of cardio-metabolic abnormalities among patients with SMI is key, so as to inform policy makers to consider formulation of guidelines for screening of metabolic abnormalities. Routine and systematic cardio-metabolic screenining will enable initiation of appropriate management of cardio-metabolic abnormalities in a timely manner, in this patient population and this may contribute towards reduced mortality and improved quality of life. Moreover, there is epidemiological evidence to suggest that routine cardio-metabolic screening could avert premature cardio-metabolic disease among patients with SMI \[[@pone.0235956.ref014]\].

Materials and methods {#sec002}
=====================

This study was part of a bigger cross-sectional study that was conducted at the outpatient mental health clinic of MRRH between October 2018 and March 2019 to identify the prevalence and associated factors of metabolic syndrome among patients with SMI \[[@pone.0235956.ref015]\]. MRRH is a public health facility in southwestern Uganda that serves about five million people, mainly from 10 catchment districts of southwestern Uganda. It also serves as a teaching hospital for Mbarara University of Science and Technology (MUST) Medical school. It is located 270 kilometers from Kampala the capital city.

The outpatient mental health clinic is run at the psychiatric ward twice every week, registering an average of 100 patients per clinic and on average about 1200 new patients per year. The clinic is run by a team of three psychiatrists, three occupational therapists, one counselor, two social workers, three psychiatric clinical officers, five psychiatric nurses, and postgraduate students.

We consecutively recruited all patients with DSM-V confirmed diagnosis of severe mental illness, both men and women, aged 18 years and above, in remission phase or having recovered from an acute episode who attended the clinic during the study period. We excluded all patients who had acute symptoms of mental illness, those who had no insight and those who were considered unable to consent by the attending clinician. We also excluded pregnant women as pregnancy would affect the interpretation of waist circumference and could potentially confound blood pressure findings in case of pregnancy-induced hypertension. Patients below 18 years of age were not enrolled for the study since their cardio-metabolic risk is generally very low.

We recruited participants consecutively as they came for review at the mental health clinic as long as they met the inclusion criteria until the sample size was obtained. The sample size of 304 was computed using the Kish Leslie formula of 1965 \[[@pone.0235956.ref016]\] using 1.96 as the critical value at 5% level of significance, taking the prevalence of metabolic syndrome among patients with severe mental illness in sub-Saharan Africa to be 23.2%, based on a study from South Africa \[[@pone.0235956.ref017]\], 0.05 as a margin of error and adjusting for a non-response rate of 10%. Participants who were eligible for the study were given comprehensive information regarding the nature and purpose of the study and a consent document was read to them in the local language or English depending on the language they understood by a trained research assistant. They were given a chance to ask questions for clarity before they provided consent. Those who accepted to participate were given a consent form to sign before enrollement in the study.

The study variables of interest included age, weight, height, abdominal circumference, blood pressure, fasting blood glucose, fasting triglyceride level (TG), total cholesterol, and high-density lipoprotein (HDL). Other variables included sex, marital status, residence (urban or rural), education level, history of smoking, history of alcohol use, psychiatric diagnosis, type of psychotropic medication and duration on psychotropic medication. The outcome variables were obesity, hypertension, diabetes mellitus, and dyslipidemia (hypertriglyceridemia, hypercholesterolemia, and low high-density lipoproteins). Data were collected by research assistants trained to handle data with confidentiality.

Measurements {#sec003}
------------

Socio-demographic and clinical data were captured using a structured questionnaire. Sociodemographic and clinical data included age, sex, marital status, level of education, tribe, religion, employment, residence, alcohol intake (history of or currently taking alcohol), smoking status (history of or currently smoking), level of physical activity (inadequate if \< 150 min of moderate exercise or 75min of vigorous/ week and adequate if ≥150 min of moderate exercise or 75min of vigorous /week), weight, height, DSM IV diagnosis, duration of mental illness, type of psychotropic medication, and duration of psychotropic medication. Weight was measured using a calibrated secca weighing scale (secca 762, GmbH and Co. KG, Hamburg, Germany) to the nearest 0.5 kg with the participant not wearing shoes and heavy clothes. Height was taken using a stadiometer to the nearest 0.5 cm with the participant standing upright with the heel, buttock, and upper back along the same vertical plane. Waist circumference was measured in cm using a non-stretchable measuring tape in the horizontal plane midway between the inferior margin of the ribs and the superior border of the iliac crest, at the end of normal expiration. Blood pressure was measured on the left arm in mmHg by auscultation method using a calibrated sphygmomanometer and a stethoscope with the participant seated on a chair with his or her back supported, feet on the floor, arm supported, and cubital fossa at heart level after 5 minutes of rest. Three readings were measured at 5-minute interval taking the first and fifth Korotkoff sounds as the systolic and diastolic blood pressure (DBP) respectively. The average of the last two systolic and diastolic measurements was taken as the mean SBP and DBP respectively \[[@pone.0235956.ref018]\].

Laboratory tests {#sec004}
----------------

The laboratory tests were fasting blood sugar and fasting lipid profile. Fasting blood sugar in mmol/l was measured using a Freestyle Optium Exceed glucometer after at least 8 hours of fasting using capillary blood obtained by finger prick. Fasting lipid profile was tested using three mls (3mls) of venous blood drawn from the cubital fossa after at least 8 hours of fasting. Those who had not fasted for the 8 hours were only included if they were willing to wait at the clinic till they completed the 8 hours fast. The samples were analyzed for total cholesterol, high-density lipoprotein (HDL), triglycerides (TGs) and low-density lipoprotein (LDL) using an ELITechGroup PIT-CHSL-4-v21 (09/2016) machine following the enzymatic-colorimetric method. All procedures were done following standard operating procedure.

Pre-diabetes was defined as fasting capillary whole blood concentration ≥6.1 mmol/l but less than 7.0 mmol/l. Diabetes mellitus was defined as fasting capillary whole blood glucose concentration ≥7.0 mmol/l or currently on medication for diabetes mellitus \[[@pone.0235956.ref019], [@pone.0235956.ref020]\]. Hypertension was defined as systolic blood pressure level ≥130 mmHg and/or diastolic blood pressure level ≥80 mmHg and/or taking medications for high blood pressure \[[@pone.0235956.ref018]\]. Body mass index (BMI) was computed by dividing the weight (kg) by the height in meters squared (m^2^) and used to develop categories of underweight, normal weight, overweight and obesity. Overweight was defined as BMI 25.0- \<30kg/m^2^ and obesity as BMI ≥30kg/m^2^ \[[@pone.0235956.ref021]\]. Abdominal obesity was defined as a waist circumference ≥102 cm in males and ≥88 cm in females \[[@pone.0235956.ref021]\]. Dyslipidemia was defined as total cholesterol ≥200mg/dl, High-Density Lipoprotein (HDL) \<40 mg/dl in males and \<50mg/dl in females or triglycerides ≥150 mg/dl according to the National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) criteria \[[@pone.0235956.ref022]\]. We then determined the proportion of participants who met each of the above definitions to be able to describe the cardio-metabolic abnormalities.

Data handling and analysis {#sec005}
--------------------------

The data were cleaned and then double entered into Epi Data 3.1, after which they were exported to STATA version 12 (Stata Corp, College Station, Texas, USA) for analysis. Descriptive analysis of all variables was done. Continuous variables were described as mean±SD while categorical variables were summarized as proportions and percentages. Categorical and continuous variables were compared based on sex using the chi-square test and Student *t-*test respectively.

Ethics {#sec006}
------

Ethical clearance for the study was obtained from the Mbarara University of Science and Technology Research Ethics Committee (No. 07/08-18) and the Uganda National Council for Science and Technology (HS 2548). We respected the guidelines of Helsinki and CIOMS-2002 (Council for International Organizations of Medical Sciences) regarding research with humans, avoiding any type of physical or moral damage. Written informed consent was obtained by research assistants from all participants.

Results {#sec007}
=======

Out of the 385 participants screened for inclusion into the study between October 2018 to march 2019, we present results of the 304 participants. We excluded 81 participants, for various reasons as shown in [Fig 1](#pone.0235956.g001){ref-type="fig"}.

![Flow chart for participants' recruitment into the study.](pone.0235956.g001){#pone.0235956.g001}

Participants' socio-demographic characteristics are presented in [Table 1](#pone.0235956.t001){ref-type="table"}. The mean age of the participants was 38.56±13.66 years. The majority (39.8%) of the participants were married/living with a partner, had attained some level of education (88.82%), were employed (82.20%) and resided in rural areas (74.34%). Only 9.8% of the participants had ever smoked and 34.87% had ever taken alcohol. There were significantly more male smokers (p = 0.028) and alcohol drinkers (p\<0.001) compared to females.

10.1371/journal.pone.0235956.t001

###### Socio-demographic characteristics of the participants.

![](pone.0235956.t001){#pone.0235956.t001g}

  Characteristic                  Overall (N = 304)   Male (N = 135)   Female (N = 169)   p-value
  ------------------------------- ------------------- ---------------- ------------------ -------------
                                  n/N (%)             n/N (%)          n/N (%)            
  **Age in years (mean±SD)**      38.56 ±13.66        37.2 ±13.55      39.65 ±13.69       0.120
  **Marital status**                                                                      **\<0.001**
   Single                         117 (38.49)         65 (48.15)       52(30.77)          
   Married /Living with partner   121(39.80)          54 (40.00)       67 (39.64)         
   Divorced/Separated/widow(er)   66 (21.71)          16 (11.85)       50 (29.59)         
  **Education Level**                                                                     0.797
   Never attended                 34 (11.18)          14 (10.37)       20 (11.830         
   ≤Secondary                     201 (66.12)         92 (68.15)       109 (64.50)        
   Tertiary/University            69 (22.70)          29 (21.48)       40 (23.67)         
  **Tribe**                                                                               0.865
   Others                         18 (5.92)           9 (6.67)         9 (5.33)           
   Bakiga                         21 (6.91)           10 (7.41)        11 (6.51)          
   Banyankole                     243 (79.93)         105 (77.78)      138 (81.66)        
   Baganda                        22 (7.24)           11 (8.15)        11 (6.51)          
  **Religion**                                                                            0.940
   Others                         35 (11.51)          16 (11.85)       19 (11.24)         
   Catholic                       137 (45.07)         60 (44.4)        77 (45.56)         
   Protestant                     109 (35.86)         50 (37.04)       59 (34.91)         
   Moslem                         23 (7.57)           09 (6.67)        14 (8.28)          
  **Employment**                                                                          0.105
   Unemployed                     45 (14.80)          15 (11.1)        30 (17.75)         
   Employed                       259 (82.20)         120 (88.89)      139 (82.25)        
  **Area of residence**                                                                   0.924
   Rural                          226 (74.34)         100 (74.07)      126 (74.56)        
   Urban                          78 (25.66)          35 (25.93)       43 (25.44)         
  **Ever Smoked**                                                                         **0.028**
   No                             274 (90.13)         116 (85.93)      158 (93.49)        
   Yes                            30 (9.87)           19 (14.07)       11 (6.51)          
  **Ever taken Alcohol**                                                                  **\<0.001**
   No                             198 (65.13)         65 (48.15)       133 (78.70)        
   Yes                            106 (34.87)         70 (51.85)       36 (21.30)         

The clinical characteristics of study participants are presented in [Table 2](#pone.0235956.t002){ref-type="table"}. The mean weight of the participants was 68.18±14.14 kg. Males were significantly taller than females (p\<0.001). The mean height for males was 1.68±0.07 m compared to 1.60±0.06 m for females. More than half (63.82%) of the participants had a diagnosis of bipolar disorder with 45.72% having been with mental illness for less than 5 years. Almost half (48.68%) of the patients had been on treatment for less than 5 years and most of the participants (81.91%) were taking antipsychotic medications with most of them (93.98) on typical antipsychotics. The majority (89.80%) had a low level of physical activity (\< 150 min of moderate exercise or 75min of vigorous exercise per week). More females than males had a low level of physical activity (p = 0.046).

10.1371/journal.pone.0235956.t002

###### Clinical characteristics of the participants.

![](pone.0235956.t002){#pone.0235956.t002g}

  Characteristic                                                Overall N = 304   Male (N = 135)   Female (N = 169)   p-value
  ------------------------------------------------------------- ----------------- ---------------- ------------------ -------------
  Weight, Kg (mean±SD)                                          68.18 ±14.14      67.13 ±12.97     69.03 ±14.99       0.244
  Height, m (Mean±SD)                                           1.64 ±0.080       1.68 ±0.07       1.60 ±0.06         **\<0.001**
  **Level of physical activity**                                                                                      **0.046**
   \< 150 min of moderate exercise or 75min of vigorous/ week   273 (89.80)       116 (85.93)      157 (92.90)        
   ≥150 min of moderate exercise or 75min of vigorous /week     31 (10.20)        19 (14.07)       12 (7.10)          
  **Mental illness**                                                                                                  **0.046**
   Bipolar disorder                                             194 (63.82)       86 (63.70)       108 (63.91)        
   Schizophrenia                                                79 (25.99)        41 (30.37)       38 (22.49)         
   Depression                                                   31 (10.20)        8 (5.93)         23 (13.61)         
  **Duration of Mental Illness (years)**                                                                              0.161
   \< 5                                                         139 (45.72)       66 (48.89)       73 (43.20)         
   5--10                                                        69 (22.70)        34 (25.19)       35 (20.71)         
   \>10                                                         96 (31.58)        35 (25.93)       61 (36.09)         
  **Duration of Psychotropic Medication (years)**                                                                     0.177
   \< 5                                                         148 (48.68)       69 (51.11)       79 (46.75)         
   5--10                                                        88 (28.95)        32 (23.70)       56 (33.14)         
   \>10                                                         68 (22.37)        34 (25.19)       34 (20.12)         
  **Participants on Antipsychotic medication**                  249 (81.91)       113 (83.70)      136 (80.47)        0.467
  **Antipsychotic class (N = 249)**                                                                                   0.918
   Typical                                                      234 (93.98)       106 (93.81)      128 (94.12)        
   Atypical                                                     15 (6.02)         7 (6.19)         8 (5.88)           
  **Mood stabilizer**                                           162 (53.29)       69 (51.11)       93 (55.03)         0.496
  **Antidepressant**                                            56 (18.42)        20 (14.81)       36 (21.30)         0.147

The proportions of participants with different cardio-metabolic abnormalities are shown in [Table 3](#pone.0235956.t003){ref-type="table"}. It should be noted that two of the participants did not undergo laboratory testing for lipid profile due to inadequate samples collected and therefore we do not present results of their fasting lipid profiles. Of all the participants, 46.38% were either overweight or obese with 33.22% having abdominal/central obesity. There were significantly more obese females compared to males (p\<0.001) with 26.04% of all females obese compared to 9.63% of males. The proportion of participants with abnormal lipid profiles were as follows; 34.11% had low high-density lipoproteins, 37.42% had hypertriglyceridemia and 34.77% had hypercholesterolemia. The proportions of participants who had pre-diabetes and diabetes mellitus were 11.18% and 9.87% respectively and 40.46% of participants had hypertension.

10.1371/journal.pone.0235956.t003

###### Cardio-metabolic abnormalities among study participants.

![](pone.0235956.t003){#pone.0235956.t003g}

  Characteristic         Overall N = 304   Male (N = 135)   Female (N = 169)   p-value
  ---------------------- ----------------- ---------------- ------------------ -------------
                         n/N (%)           n/N (%)          n/N (%)            
  Obesity based on BMI                                                         **\<0.001**
   Overweight            84 (27.63)        32 (23.70)       52 (30.77)         
   Obese                 57 (18.75)        13 (9.63)        44 (26.04)         
  Abdominal obesity      101 (33.22)       18 (13.33)       83 (49.11)         **\<0.001**
  Pre-Diabetes           34 (11.18)        16 (11.85)       18 (10.65)         0.943
  Diabetes Mellitus      30 (9.87)         13 (9.63)        17 (10.06)         0.901
  Hypertension           123 (40.46)       52 (38.52)       71 (42.01)         0.538
                         **N = 302**       **N = 134**      **N = 168**        
  Low HDL                103 (34.11)       40 (29.85)       63 (37.50)         0.164
  Hypertriglyceridemia   113 (37.42)       50 (37.31)       63 (37.50)         0.973
  Hypercholesterolemia   105 (34.77)       40 (29.85)       65 (38.69)         0.109

**BMI**: Body Mass Index, **HDL:** High-Density Lipoprotein.

Discussion {#sec008}
==========

Our results show high proportions of cardio-metabolic abnormalities among patients with SMI. According to our findings, one in three (33.22%) participants had abdominal obesity and two in five (46.38%) were either overweight or obese. This is slightly lower than the one in two (50%) that was found in two meta-analyses that reported the prevalence of cardio-metabolic abnormalities among patients with SMI \[[@pone.0235956.ref005], [@pone.0235956.ref006]\]. The proportion of participants with obesity in our study is much lower than that found in a study in North America which found a prevalence of obesity of almost 80% in a sample of more than 10,000 psychiatric outpatients with schizophrenia and bipolar disorder \[[@pone.0235956.ref023]\]. It is however comparable to the prevalence of obesity found in one meta-analysis of studies published between 1990 and 2010 which reported a prevalence of 45--55% among patients with schizophrenia and 21--49% among those with bipolar disorder \[[@pone.0235956.ref024]\]. The prevalence in our study was lower probably because the majority (93.98%) of the participants taking antipsychotics were on typical antipsychotics yet obesity among patients with SMI has been mainly associated with new generation (atypical) antipsychotics \[[@pone.0235956.ref008], [@pone.0235956.ref025]\]. In addition, 89.80% of all the participants had reduced levels of physical activity (\<150 min of moderate exercise or 75min of vigorous exercise per week) yet reduced physical activity is a known risk factor for obesity. Based on BMI, 18.75% of all the participants were obese and this is 2.6 times higher than the prevalence of 7% found in a study among adults ≥ 18 years in Eastern Uganda \[[@pone.0235956.ref026]\] and is also higher than the global prevalence of 13% \[[@pone.0235956.ref027]\]. Our findings underscore the need for routine and systematic cardio-metabolic screening among patients with SMI in Uganda. Furthermore, there is need for interventions to address the high prevalence of obesity among patients with SMI. These interventions include: increase in physical activity, diet modification, careful selection of psychotropic medication for these patients based on their base-line laboratory findings; since some of the psychotropic medication such as atypical antipsychotic medication predispose patients to increased risk of obesity.

The proportion of participants with hypertension was 40.46%, which falls in the range found in a meta-analysis by De Hert and colleagues that found a prevalence of 19--58% among patients with schizophrenia and 35--61% among those with bipolar disorder \[[@pone.0235956.ref024]\]. This proportion is 1.5 times higher than the national prevalence of 26.4% in the general Ugandan population found in a nation-wide non-communicable disease (NCD) survey of 2014 \[[@pone.0235956.ref028]\] as well as the global prevalence of hypertension of 26% in the general population \[[@pone.0235956.ref029]\]. It is therefore important that patients with severe mental illness are screened for hypertension routinely during their reviews. This will enable early detection and timely management of hypertension in patients with SMI in Uganda.

One in three patients with SMI in this study had hypertriglyceridemia (37.42%) and hypercholesterolemia (34.77%) and about one in four (34.11%) had low levels of high-density lipoproteins (HDL). This is slightly lower than the 40% prevalence of hypertriglyceridemia found in the meta-analysis by Vancampfort and colleagues that described the prevalence of cardio-metabolic abnormalities among patients with SMI \[[@pone.0235956.ref006]\]. These proportions are however at least five times higher than those found in a community-based survey in southwestern Uganda in which hypercholesterolemia was at 6.0% and triglyceridemia at 5.0% \[[@pone.0235956.ref030]\]. This can be explained by the high levels of obesity and overweight (46.38%) in this population and the fact that some antipsychotic drugs affect lipid and triglyceride metabolism independent of weight gain \[[@pone.0235956.ref031]\]. Additionally, the unhealthy dietary habits and sedentary lifestyles of patients with SMI, predispose them to dyslipidemias \[[@pone.0235956.ref032]\]. Our findings, therefore call for interventions that are aimed at preventing/reducing the burden of dyslipidemias in the study population. These interventions include: carefull selection the psychotropic medications, dietary modifications and increased physical activity, among others.

Based on fasting blood sugar, 9.87% of all the participants had diabetes mellitus, a proportion three times higher than the 2.7% for urban areas and nine times higher than the 1.0% for rural areas of Uganda reported in a nation-wide non-communicable disease risk factor survey \[[@pone.0235956.ref033]\]. It is, however, lower than the global range of 10--15% among patients with SMI \[[@pone.0235956.ref034], [@pone.0235956.ref035]\]. Furthermore, our findings are in agreement with findings from other studies where the prevalence of DM in patients with schizophrenia and bipolar disorder was estimated to be two to three times \[[@pone.0235956.ref034], [@pone.0235956.ref035]\] or even four times \[[@pone.0235956.ref036], [@pone.0235956.ref037]\] higher than in the general population.

Overall, our findings demonstrate high prevalence of cardio-metabolic abnormalities among patients with SMI in southwestern Uganda. This emphasises the need for routine cardio-metabolic screening strategies in this patient population. Furthermore, there is need to incorporate medical care services into mental health care, as well as designing local and national guidelines for screening and management of cardio-metabolic abnormalities among patients with SMI.

Our study had limitations. First, the study was conducted in one hospital and findings may not be generalizable beyond the population of patients attending the mental health clinic at MRRH. Secondly, the study may have been subjected to social acceptability bias from participants wanting to provide socially desirable responses to questions about risky lifestyles of patients with severe mental illness such as smoking and alcohol consumption. Thirdly, the sample size was powered on the known prevalence of metabolic syndrome and not on the individual cardio-metabolic abnormalities making it difficult to confidently report the prevalence of the individual cardio-metabolic abnormalities.

Conclusion {#sec009}
==========

There is a high level of cardio-metabolic abnormalities among patients with severe mental illness at MRRH and thus metabolic screening for these abnormalities should be routinely done during psychiatric reviews. There is also need for national guidelines for screening of metabolic abnormalities among patients with SMI so that these abnormalities can be detected early enough at stages where they can either be reversed or delayed to progress to cardiovascular disease. There is a need to educate patients with SMI on lifestyle modification such as quitting smoking and alcohol consumption, exercising and diet modification. Caretakers of these patients should be involved in these health education talks so that they can provide social support to these patients.
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======================
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Dear Dr. Agaba,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

This manuscript describes the prevalence of abnormalities in cardio-metabolic risk factors among persons with a severe mental illness in southwestern Uganda. The manuscript shows a high level of abnormalities in SMI patients, which is alarming. I believe that the authors conducted a study that is very important for the organization of the mental health care situation in Uganda and that their data emphasizes the need for routine screening for cardio-metabolic abnormalities. I believe that the authors can significantly improve the paper by placing the outcomes as described in the paper in a wider context.

Major revisions

1\.     The authors state that the aim of this study is to describe the cardio-metabolic abnormalities among patients with SMI attending the specific clinic at MRRH. However, after reading the introduction, it is unclear why the authors want to know these percentages; what do they want to do with these numbers? It is also unclear what the reference category is to which these numbers will be compared. Do the authors want to know the percentage of abnormalities in SMI patients as compared to the general population in Uganda, or as compared to SMI population in other countries? And why do the authors want to know this? The context of this study could be much more understandable if the authors explicitly state the underlying aim of why they want to know these percentages.

2\.     For the reader, the procedure of including patients in the study is unclear. The manuscript does not provide any information about the procedure to inform patients about the study and to sign informed consent (should be described in the method section, and not as one line in the ethics section). It is also unclear how many patients were eligible (i.e. how many patients were invited to participate), and how many patients refused to sign informed consent (drop-out; should be described in the Results section). In addition, in the discussion, the authors mention the sample size calculation (line 236), which is not even described in the method section. This is all very important information that is now lacking in the manuscript.

3\.     In the method section (line 86), the authors mention that they recruited a total of 304 patients. This is a result and should therefore be in the results section.

4\.     The authors state that the fasting blood sugar levels were obtained after eight hours of fasting. Is it realistic that patients had been fasting for eight hours? Or could the percentage of persons with pre-diabetes or diabetes be influenced by non-fasting blood sugar levels?

5\.     In the results section, the authors give number for 'smokers', 'for ever taken alcohol',  and for 'physical activity'. It is unclear what questions were used to get these data; I believe this should be mentioned in the method section.

6\.     Table 2: did the authors only include persons with the diagnosis 'Schizophrenia',  or were other psychotic diagnoses related to schizophrenia also included?

7\.     Table 2: the variables mentioned in the table are not clear. 'Antipsychotic' is not bold, and as a reader I do not have a clue what the authors mean with this. Please clarify. Also, in Table 2, the use of the heading 'Duration of psychotropic medication (yes)', suggests that everyone uses psychotropic medication. After calculating the total numbers, is seems indeed that everyone is using medication. But, why are 'antipsychotics' framed as a separate variable and why are the types of medication for depression or bipolar disorder nog given? The order of the table and the missing information leaves the reader with questions, please adjust the table.

8\.     Discussion: because for the reader, it is unclear why the authors would like to study these percentages (what the bigger aim is of knowing these numbers?), the discussion reads like a story summing up percentages without truly delivering a message. The percentages from the study are compared to percentages in either other SMI populations and to percentages in the general population of Uganda. I think the authors could truly improve the discussion by making clear what they want to do with these numbers, and to whom they want to compare these numbers, so that they can come up with a more in-depth discussion what could be done with these numbers. Now, the discussion only represents four paragraphs in which the numbers are compared to others, without drawing a conclusion. I think only two paragraphs should be spend on comparing these numbers, and thereafter, the authors should focus on the wider picture. Also, the phrase 'unhealthy lifestyles' pops up now and then, it is slightly touched, but I think the authors have more ideas about the role of unhealthy lifestyles and the early detection of cardio-metabolic abnormalities in solving the problem of these high cardio-metabolic abnormalities. 

9\.     The conclusion summaries actually all that the reader wants to know more of in the introduction and the discussion. I think the conclusion has a very clear message of the why the authors want to know these numbers and what they aim to do after knowing these numbers. I think that the message of the conclusion should be highlighted more in the introduction (why do you want to know this) and in the discussion (now you know this, what can you do with1 his information).

Minor revisions

1\.     Please be consistent in the use of the word cardio-metabolic (cardio-metabolic vs cardiometabolic).

2\.     The sentence in the abstract from line 16 to 20 is unreadable, please rephrase.

3\.     The author describes in line 46 to 50 the known percentages of cardio-metabolic abnormalities in SMI patients found in two previous meta-analyses. For the reader it's unclear why the percentage of smokers is included in this summary, since this is a lifestyle behavior, not a cardio-metabolic abnormality. 

4\.     The Introduction reads as one large paragraph. I believe that the use of more paragraphs would provide a better structure of the paper. The author could for example start a new paragraph from line 54. Also, the method section could use some paragraphs.

5\.     In line 59, for the reader it's unclear to what the word 'they' refers; it mostly reads as it refers to 'lifestyle modification approaches', but this is probably not what is meant. Please clarify in the text. 

6\.     It is unclear what is meant with 'acute symptoms with no insight' (line 80). Please rephrase.

7\.     The words 'history of smoking' are mentioned twice in the summary (line 90 and 91).

8\.     When starting a new paragraph, it's not preferable to start the first sentence with 'These'  since the reader is unaware to what the word 'these' refers (line 112).

9\.     Line 117: please do not use a capital for the word Triglycerides

10\.     Please delete the word 'obese' in line 128, as it is redundant.

11\.     In my opinion, the sentence about data collection (line 145) should be in de method section, not in the ethics section.

12\.     In the tables, I believe it's preferable to make the significant p-values bold, so it's easier to scan the table.

13\.     In the tables, I would prefer to see the mean ± standarddeviation not including ( ). 

14\.     In Table 1, the Overall numbers for Single persons do miss a ) . I think the 0 should be deleted and replaced by a ), also to keep the number of decimals equal in the table. In Table 1, also, a space between 'Female(N=169)' is needed.

15\.     The marital status 'died' is a bit odd; I think 'widow(er)' would be more appropriate.

16\.     Please replace the '&' with 'and' throughout the whole manuscript

17\.     Please write numbers below ten as a word instead of a number, e.g., '3 psychiatrists' should be 'three psychiatrists'

18\.     Please be consistent in the use of a space between the number and the percentage-sign throughout the whole manuscript (e.g. either 10% or 10 %).

19\.     Describe square meters using the superscript function (i.e. m2)

20\.     Line 192: it's unclear where the word 'that' refers to, please clarify.
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RESPONSE TO REVIEWER'S COMMENTS

Major revisions

1\. The authors state that the aim of this study is to describe the cardio-metabolic abnormalities among patients with SMI attending the specific clinic at MRRH. However, after reading the introduction, it is unclear why the authors want to

know these percentages; what do they want to do with these numbers? It is also unclear what the reference category is to which these numbers will be compared. Do the authors want to know the percentage of abnormalities in SMI patients as compared to the general population in Uganda, or as compared to SMI population in other countries? And why do the authors want to know this? The context of this study could be much more understandable if the authors explicitly state the underlying aim of why they want to know these percentages.

Response: We have worked on the introduction to address this. We have added a paragraph that describes why we need to know the percentages of cardiometabolic abnormalities among patients with SMI. It reads "Although over 30% of Ugandans have some form of mental illness, there are no national or hospital-based screening guidelines for cardio-metabolic abnormalities among patients with SMI. Thus far, data on cardio-metabolic abnormalities among patients with SMI in Uganda are limited. The aim of this study was to describe the cardio-metabolic abnormalities among patients with SMI attending the outpatient mental health clinic at Mbarara Regional Referral Hospital (MRRH). Documenting the burden of cardio-metabolic abnormalities among patients with SMI is key, so as to inform policy makers to consider formulation of guidelines for screening of metabolic abnormalities. Routine and systematic cardiometabolic screening will enable initiation of appropriate management of cardio-metabolic abnormalities in a timely manner, in this patient population which will contribute towards improved quality of life. Moreover, there is epidemiological evidence to suggest that routine cardiometabolic screening could avert premature cardiometabolic disease among patients with SMI." (line 65-77)

2\. For the reader, the procedure of including patients in the study is unclear. The manuscript does not provide any information about the procedure to inform patients about the study and to sign informed consent (should be described

in the method section, and not as one line in the ethics section). It is also unclear how many patients were eligible (i.e. how many patients were invited to participate), and how many patients refused to sign informed consent (drop-out;

should be described in the Results section). In addition, in the discussion, the authors mention the sample size calculation (line 236), which is not even described in the method section. This is all very important information that is

now lacking in the manuscript.

Response:

The procedure for providing information about the study and to sign informed consent as well as details of sample size have been included: "We recruited participants consecutively as they came for review at the mental health clinic as long as they met the inclusion criteria until the sample size was obtained. The sample size of 304 was computed using the Kish Leslie formula of 1965 using 1.96 as the critical value at 5% level of significance, taking the prevalence of metabolic syndrome among patients with severe mental illness in sub-Saharan Africa to be 23.2%, based on a study from South Africa, 0.05 as a margin of error and adjusting for a non-response rate of 10%.

Participants who were eligible to participate in the study were given comprehensive information regarding the nature and purpose of the study and a consent document was read to them in the local language or english depending on the language they understood by a trained research assistant. They were given a chance to ask questions for clarity before they provided consent. Those who accepted to participate were given a consent form to sign." (Line 100-111) Materials & Methods section

About the number of patients approached, those that declined or dropped out: A study flow chart has been included to address. Results section: line 186-198

A total of 385 participants were eligible but 81 were excluded (reasons listed in the flow chart) to remain with 304 who were recruited.

3\. In the method section (line 86), the authors mention that they recruited a total of 304 patients. This is a result and should therefore be in the results section.

Response: This has been addressed. The statement has been corrected (line 100) and the number reported in results section.

4\. The authors state that the fasting blood sugar levels were obtained after eight hours of fasting. Is it realistic that patients had been fasting for eight hours? Or could the percentage of persons with pre-diabetes or diabetes be influenced by non-fasting blood sugar levels?

Response: We made sure that all the participants had fasted for 8 hours. Those who had not fasted for the 8 hours were only included if they were willing to wait at the clinic till, they completed the 8 hours fast. This has been clarified in methods section. Line 147-148.

5\. In the results section, the authors give number for 'smokers', 'for ever taken alcohol', and for 'physical activity'. It is unclear what questions were used to get these data; I believe this should be mentioned in the method section.

Response: Thank you for this comment. We have improved this in the methods section under measurements (line 124-128)

6\. Table 2: did the authors only include persons with the diagnosis 'Schizophrenia', or were other psychotic diagnoses related to schizophrenia also included?

Response: During participant recruitment, we only recruited participants with a confirmed diagnosis of schizophrenia and not other psychotic disorders since our inclusion criteria was SMI (bipolar, Major depression and schizophrenia)

7\. Table 2: the variables mentioned in the table are not clear. 'Antipsychotic' is not bold, and as a reader I do not have a clue what the authors mean with this. Please clarify. Also, in Table 2, the use of the heading 'Duration of

psychotropic medication (yes)', suggests that everyone uses psychotropic medication. After calculating the total numbers, is seems indeed that everyone is using medication. But, why are 'antipsychotics' framed as a separate variable and why are the types of medication for depression or bipolar disorder not given? The order of the table and the missing information leaves the reader with questions, please adjust the table.

Response: Table 2 has been improved to bolden "antipsychotic" but has also been improved to "participants on antipsychotic medication"

It is true everyone was on psychotropic medication but not everyone was taking an antipsychotic medication. To our understanding, psychotropic medication includes antipsychotics, mood stabilizers and antidepressants. We give details of the class of antipsychotic medication and not for mood stabilizers or anti-depressants: This is informed by literature that shows differences in causation of cardiometabolic abnormalities among patients with SMI according to class of antipsychotic medication yet we don't find any special considerations for mood stabilizers & antidepressants in literature.

8\. Discussion: because for the reader, it is unclear why the authors would like to study these percentages (what the bigger aim is of knowing these numbers?), the discussion reads like a story summing up percentages without truly

delivering a message. The percentages from the study are compared to percentages in either other SMI populations and to percentages in the general population of Uganda. I think the authors could truly improve the discussion by

making clear what they want to do with these numbers, and to whom they want to compare these numbers, so that they can come up with a more in-depth discussion what could be done with these numbers. Now, the discussion only

represents four paragraphs in which the numbers are compared to others, without drawing a conclusion. I think only two paragraphs should be spend on comparing these numbers, and thereafter, the authors should focus on the wider

picture. Also, the phrase 'unhealthy lifestyles' pops up now and then, it is slightly touched, but I think the authors have more ideas about the role of unhealthy lifestyles and the early detection of cardio-metabolic abnormalities in solving the problem of these high cardio-metabolic abnormalities.

Response: Thank you for the guidance. We have tried to improve the discussion to make sense out of the numbers and we hope it reads better now.

For example:

I. "Our findings underscore the need for routine and systematic cardio-metabolic screening among patients with SMI in Uganda. Furthermore, there is need for interventions to address the high prevalence of obesity among patients with SMI. These interventions include: increase in physical activity, diet modification, careful selection of psychotropic medication for these patients based on their base-line laboratory findings; since some of the psychotropic medication such as atypical antipsychotic medication predispose patients to increased risk of obesity." Line 252-259

II\. "Overall, our findings demonstrate high prevalence of cardio-metabolic abnormalities among patients with SMI in southwestern Uganda. This emphasises the need for routine cardiometabolic screening strategies in this patient population. Furthermore, there is need to incorporate medical care services into mental health care, as well as designing local and national guidelines for screening and management of cardiometabolic abnormalities among patients with SMI." Line 292-297

9\. The conclusion summaries actually all that the reader wants to know more of in the introduction and the discussion. I think the conclusion has a very clear message of the why the authors want to know these numbers and what they aim to do after knowing these numbers. I think that the message of the conclusion should be highlighted more in the introduction (why do you want to know this) and in the discussion (now you know this, what can you do

With this information).

Response: Thank you for this comment and for your guidance on how best to improve our paper. The suggestions have been included in the introduction and discussion sections.

Minor revisions

1\. Please be consistent in the use of the word cardio-metabolic (cardio-metabolic vs cardiometabolic).

Response: The word has been changed to cardio-metabolic across the entire document.

2\. The sentence in the abstract from line 16 to 20 is unreadable, please rephrase.

Response: The sentence has been rephrased. Hope it reads better. "Although over 30% of Ugandans have some form of mental illness, there are no national or hospital-based screening guidelines for cardio-metabolic abnormalities among these patients, a general trend in most low-income countries. The screening rates for cardio-metabolic abnormalities in most low-income countries are at only 0.6%." Line 17- 21

3\. The author describes in line 46 to 50 the known percentages of cardio-metabolic abnormalities in SMI patients found in two previous meta-analyses. For the reader it's unclear why the percentage of smokers is included in this

summary, since this is a lifestyle behaviour, not a cardio-metabolic abnormality.

Response: The statement has been improved. The percentage of smokers has been eliminated because it is not a cardio-metabolic abnormality. (Line 52-54)

4\. The Introduction reads as one large paragraph. I believe that the use of more paragraphs would provide a better structure of the paper. The author could for example start a new paragraph from line 54. Also, the method section

could use some paragraphs.

Response: we have improved the sections by creating more paragraphs in the introduction and methods section.

5\. In line 59, for the reader it's unclear to what the word 'they' refers; it mostly reads as it refers to 'lifestyle modification approaches', but this is probably not what is meant. Please clarify in the text.

Response:

The statement has been improved to: "The low screening rates result in late diagnosis of these abnormalities at stages where lifestyle modification approaches are no longer very beneficial, thus leading to progression to cardiovascular disease." Line 62-64

6\. It is unclear what is meant with 'acute symptoms with no insight' (line 80). Please rephrase.

Response: The statement has been rephrased to "We excluded all patients who had acute symptoms of mental illness, those who had no insight and those considered unable to consent by the attending clinician" Line 95-97

7\. The words 'history of smoking' are mentioned twice in the summary (line 90 and 91).

Response: This has been corrected. The repeated word has been deleted.

8\. When starting a new paragraph, it's not preferable to start the first sentence with 'These' since the reader is unaware to what the word 'these' refers (line 112).

Response: This has been corrected. (line 146)

9\. Line 117: please do not use a capital for the word Triglycerides

Response: we have written the word properly as triglycerides (line 152)

10\. Please delete the word 'obese' in line 128, as it is redundant.

Response: The word has been removed.

11\. In my opinion, the sentence about data collection (line 145) should be in de method section, not in the ethics section.

Response: The sentence has been moved to methods section (Line 120-121)

12\. In the tables, I believe it's preferable to make the significant p-values bold, so it's easier to scan the table.

Response: the significant p-values have been made bold in all tables.

13\. In the tables, I would prefer to see the mean ± standard deviation not including ( ).

Response: This has been corrected in all tables and in the text.

14\. In Table 1, the Overall numbers for Single persons do miss a ) . I think the 0 should be deleted and replaced by a), also to keep the number of decimals equal in the table. In Table 1, also, a space between 'Female(N=169)' is needed.

Response: Table 1 has been corrected as per the suggestions

15\. The marital status 'died' is a bit odd; I think 'widow(er)' would be more appropriate.

Response: This has been corrected in table 1

16\. Please replace the '&' with 'and' throughout the whole manuscript

Response: The correction has been made all through the document.

17\. Please write numbers below ten as a word instead of a number, e.g., '3 psychiatrists' should be 'three psychiatrists'

Response: the changes have been made all through the document. For example: line 84-86

18\. Please be consistent in the use of a space between the number and the percentage-sign throughout the whole

manuscript (e.g. either 10% or 10 %).

Response: The change to use of no space has been effected all through the document

19\. Describe square meters using the superscript function (i.e. m2)

Response: This has been corrected. Line: 151-153

20\. Line 192: it's unclear where the word 'that' refers to, please clarify

Response: This has been corrected to: "the prevalence of obesity" Line 242

###### 

Submitted filename: Response to Reviewers.docx

###### 

Click here for additional data file.

10.1371/journal.pone.0235956.r003

Decision Letter 1

Feng

Ying-Mei

Academic Editor

© 2020 Ying-Mei Feng

2020

Ying-Mei Feng

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

26 Jun 2020

Cardio-metabolic abnormalities among patients with severe mental illness at a Regional Referral Hospital in southwestern Uganda

PONE-D-19-20354R1

Dear Dr. Agaba,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Kind regards,

Ying-Mei Feng

Academic Editor

PLOS ONE

10.1371/journal.pone.0235956.r004

Acceptance letter

Feng

Ying-Mei

Academic Editor

© 2020 Ying-Mei Feng

2020

Ying-Mei Feng

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

7 Jul 2020

PONE-D-19-20354R1

Cardio-metabolic abnormalities among patients with severe mental illness at a Regional Referral Hospital in southwestern Uganda

Dear Dr. Agaba:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr Ying-Mei Feng

Academic Editor

PLOS ONE

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.
